Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tennis elbow injection and physiotherapy trial
ACTRN12609000051246Phase 4Recruiting
- Sponsor
- Professor Bill Vicenzino
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone acetonide, lidocaine and sodium chloride in Lateral Epicondylitis (LET) (4 arms), sponsored by Professor Bill Vicenzino. Primary endpoints: General improvement at 52 weeks and Pain-free grip force at 52 weeks. Started Aug 2008; status: recruiting.
02
Drugs
triamcinolone acetonidelidocainesodium chloride
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on ACTRN12609000051246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000051246.